These lab-designed options were not produced with recreational use in your mind. From the 1990s, John W. Huffman and a group of fellow chemists at Clemson University created several of the first formulation for synthetic cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts of cann